Combined Administration of the GPVI-Fc Fusion Protein Revacept with Low-Dose Thrombolysis in the Treatment of Stroke

Abstract

In contrast to using the equally effective full dose of rtPA, intracranial bleeding was not increased by low-dose rtPA combined with Revacept. Therefore, addition of Revacept to low-dose rtPA does not incur safety risks, but improves efficacy of treatment.